ARID1A and neoplasm: More importantly, A20 enhancer activation abrogated the difference in tumor growth between mice bearing WT and Arid1a KO cells (Fig. 4k), and MDSCs, CD8+ T cells and IFNγ+ expressing CD8+ T cells were present in similar proportions (Supplementary Fig. 4k).